Drug-Price Bill Pruned in Senate in Partial Industry Win
By Erik Wasson | Alexander RuoffThe bill would still allow Medicare to negotiate the prices for drugs it provides under Part B and Part D for the first time.
August 03, 2022
New SEC Guidance Tackles How to Handle Conflicts of InterestIn addressing conflicts under Reg BI and the Advisers Act fiduciary standard, disclosure isn't enough, the SEC warns.
August 01, 2022
Study Examines Who Wants Advice Within Retirement PlansRetirement savers using online tools were more likely to seek advice; those in TDFs were less likely.
August 01, 2022
Are Clients Too Scared of Long-Term Care Costs?A T. Rowe Price vice president thinks that might be the case. Others have different ideas.
August 01, 2022
New York Asks Life Insurers for Disaster Plan UpdatesAgents and advisors can use the department's disaster prep questionnaires, too.
July 29, 2022
El-Erian, Crescenzi Explain Why Investors Are Betting on the Fed"The market is looking for a pivot ... when the only reason you would get it is [if] the economy collapses," said economist Mohamed El-Erian.
July 28, 2022
Schumer-Manchin Deal May Raise Some Life Insurers' TaxesHere are H.R. 5376 highlights for life, health and annuity advisors.
July 26, 2022
Consumer Interest in Asset Protection May Be FallingAllianz Life found that the percentage of survey takers interested in protected products is shrinking.